Skip to main content
. 2018 Dec;59(12):1809–1816. doi: 10.2967/jnumed.118.208637

FIGURE 6.

FIGURE 6.

(A) A 60-y-old patient with luminal B (HER-2–negative) breast cancer (blue arrows) and axillary lymph node metastasis (red arrows) showing intense 18F-alfatide II uptake but no 18F-FDG uptake. (B) A 54-y-old patient with luminal A (HER-2–negative) breast cancer (blue arrows) showing increased 18F-alfatide II uptake, but no 18F-FDG uptake, and distant metastases with larger numbers and more intense uptake (green arrows) by 18F-alfatide II than by 18F-FDG.